Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohortTenna Vesterman Henriksen, Claus L. Andersen, Christina Demuth et al.|Annals of Oncology|2023Cited by 71
Perioperative lipid-enriched enteral nutrition versus standard care in patients undergoing elective colorectal surgery (SANICS II): a multicentre, double-blind, randomised controlled trialEmmeline G. Peters, Misha Luyer, Jonas Amstrup Funder et al.|The Lancet. Gastroenterology & hepatology|2018Cited by 45
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Claus L. Andersen, Jesper Nors et al.|European Journal of Cancer|2024Cited by 19
Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal CancerJonas Kabel, Claus L. Andersen, Tenna Vesterman Henriksen et al.|Cancers|2023Cited by 12
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancerNadia Øgaard, Claus L. Andersen, Sarah Østrup Jensen et al.|British Journal of Cancer|2024Cited by 10